Veloxis Promotes John Weinberg to Chief Operating Officer SYS-CON Media (press release) EnvarsusĀ® is an investigational drug that is being developed as a once daily tablet version of tacrolimus, with improved bioavailability, consistent pharmacokinetic performance and reduced peak to trough variability when compared to currently approved ... |
